As of January 22, 2025, Theranexus SA (ALTHX.PA) has a market cap of $4.576 million USD. According to our data, Theranexus SA is ranked No.9068 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $4.58 M |
-5.88%
|
Dec 31, 2024 | $4.86 M |
-48.39%
|
Dec 29, 2023 | $9.42 M |
-36.00%
|
Dec 30, 2022 | $14.72 M |
-64.65%
|
Dec 31, 2021 | $41.64 M |
2,554.16%
|
Dec 31, 2020 | $1.57 M |
-93.87%
|
Dec 31, 2019 | $25.57 M |
1,596.43%
|
Dec 31, 2018 | $1.51 M |
20.67%
|
Dec 29, 2017 | $1.25 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Santander
SAN
|
$74.22 B |
0.606 B
|
Spain
|
First Majestic Silver
AG
|
$2.70 B |
10.900 M
|
Canada
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Market Cap | = | ALTHX.PA Stock Price | * | ALTHX.PA Shares Outstanding |
= | $0.57 | * | 8.08 M | |
= | $4.58 M |